Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
Published Online: 2021-07-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: A Keith Stewart•Abhinav Deol•Adam D Cohen•Alexander Lesokhin•Alicia J Allred•Andrzej Jakubowiak•Arnob Banerjee•Carolyn C Jackson•David Avigan•Deepu Madduri•Dong Geng•Elizabeth O'Donnell•Enrique Zudaire•Farah Hossain•Frank Fan•Indrajeet Singh•Jeffrey Infante•Jenna D Goldberg•Jesus G Berdeja•Jordan M Schecter•Marlene J Carrasco-Alfonso•Mounzer Agha•Muhammad Akram•Myo Htut•Nikhil C Munshi•Parameswaran Hari•Saad Z Usmani•Sen Hong Zhuang•Sundar Jagannath•Syed Rizvi•Thomas Martin•Tzu-Min Yeh•William Deraedt•Xiaoling Wu•Yi Lin•Yunsi Olyslager
